Status:
COMPLETED
Association of Placenta Removal Method and Postpartum Leucocytosis
Lead Sponsor:
Haydarpasa Numune Training and Research Hospital
Conditions:
Cesarean Section Complications
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Cesarean delivery is one of the most common major abdominal operation in women worldwide. The incidence of postpartum infection has been estimated to be 1-4% after vaginal delivery and 10-20% after Ce...
Detailed Description
Objective: Cesarean section is one of the most common major abdominal operation in women worldwide and its rate is increasing every year. Although cesarean birth is considered as safe, it is a potent...
Eligibility Criteria
Inclusion
- Nonanemic pregnancies
- Singleton pregnancies
- Term pregnancies
- Elective cesarean sections
Exclusion
- Patients having umbilical cord prolapse,
- Patients having placenta previa
- Patients having preterm rupture of mebranes
- Patients having maternal infection
- Patients having multiple gestation
- Patients having antepartum hemorrhage
- Patients having severe pre-eclampsia
- Patients having placenta previa
- Patients having placental abruption
- Patients having uncontrolled gestational diabetes
- Heart disease
- Liver disorders
- Renal disorders
- Coagulopathy
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04323241
Start Date
October 1 2019
End Date
January 20 2021
Last Update
February 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Health Sciences Turkey
Istanbul, Turkey (Türkiye)